You can't just dismiss a Federal subpoena and assume it will just disappear. it's a very serious inquiry. More importantly, the legal uncertainty will now be an overhang on the stock. Battleground stocks are way too risky, which is why I was stopped out today, but I will buy back whenever it settles down.
They had 24,000 on the ask awhile ago, and then they pulled it when the PPS got to that number. They're out there borrowing shares they can't possibly pay back.
Don't feel sorry for me, let's compare portfolios, shall we? I bought GRPO at $32, and ANET at $31, and I still hold them. How are you doing? LAKE is nothing more than a play toy for me, although I do believe the shorts will eventually get burned.
This is typical. They put a big number on the ask on Level II, just to intimidate others. Then it never executes, because it was a fake number. If you're still with me here, just watch $13.20 on Level II.
Beyond belief.....Just watch Level II......Someone throws a big number on the ask to intimidate, and almost
instantly it vanishes, so it doesn't get taken out by a buyer. If you're still with me here, just watch $13.20 right now.
Well in my experience, the street shoots first, and asks questions later. That's exactly what they're doing. I expect the analysts to come out and defend the stock, like they always do, but honestly what can they say? They (the analysts) certainly are not privy to everything going on inside the co.
This is not their first subpoena.....and about 3 weeks ago, the company and analysts sounded the all clear signal, and it appeared that there were no issues with the pricing of digoxin sales. That's when LCI stock took off from about $40 to almost $60. Now, all of a sudden they're not in the clear? I'm assuming this is a new Federal inquiry, that had nothing to do with the previous one. Thoughts?
Roche already made a huge business commitment to NLNK, so they may want to buy the entire portfolio.
Investors are certainly happy with what they heard from NLNK today....Great report, the company is very upbeat. Ebola is minutia, this company's cancer drug and the relationship with Roche is what's driving the PPS higher.
You know what Gregg? The Fast money guys, Cramer, and all the rest should be off the air. This stock may be down over $10 today, and it was trading over $247 in pre market. They missed numbers, sales are down, I think the party is over. Watch Cramer spin it however the market reacts, to fit his agenda.
Filling gaps is a myth, and in many cases just a self fulfilling prophecy. Many gaps get filled, breakaway gaps usually don't. LAKE shared some very substantive business news regarding the demand for their products, so in this case the sentiment became very positive. Given that, plus the enormous short interest, I think the stock will see $17-$18 long before it ever goes in the $11's.
That's all you need to know. Why are people commenting about what news they will hear tomorrow? I didn't know they do their quarterly report tomorrow, because I don't see it posted anywhere. But to be honest, who cares about tomorrow? This is not a day trading stock, it's a core holding in the biotech space.
Learn what exponential growth means, and then get back to us. ASP means nothing at this point.
They missed earnings, revenue increase was expected, many bought in after hours last night way over $106, today's report is very disappointing, and if Cramer were a man, he would admit he was wrong.
They have no idea who or what Alibaba the company does, and they could care less. China is slowing dramatically, and so is their middle class. Margins were down, they only met EPS, and they're overvalued.
Ok, here goes...."Sorry everyone, I was wrong." "This is a Chinese company after all, they're held to different standards." "Buy Facebook instead on the pullback." "Wait until BABA goes to the low $90's, then maybe pull the trigger."